Business
Novo Nordisk’s FDA-Approved GLP-1s Now Available With Hims & Hers
SAN FRANCISCO, March 26, 2026--Hims & Hers Health, Inc. (NYSE: HIMS) today announced that a broad assortment of Novo Nordisk’s FDA-approved GLP-1 medications are available to eligible customers, including the Wegovy® pill, which is the only FDA-approved GLP-1 weight loss pill.1 As a part of a collaboration with Novo Nordisk, Hims & Hers is making it simpler for customers to access FDA-approved GLP-1 medications which are now available at more affordable prices, with more doses and delivery metho
About this update from Hims & Hers Health, Inc.
[{"type":"image","alt":"Starting today, eligible customers can access a broad assortment of treatment options, including the only FDA-approved GLP-1 weight loss pill.","displaySize":"","headline":null,"caption":"Starting today, eligible customers can access a broad assortment of treatment options, including the only FDA-approved GLP-1 weight loss pill.","credit":null,"className":"","disableSlideshowImg":false,"size":{"original":{"width":480,"height":325,"url":"https://media.zenfs.com/en/business-wire.com/0274e24adeeb390ecd36e5a03bc1f293"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/3knTTDvCwhFiaflH_bxUxQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTk2MDtoPTY1MA--/https://media.zenfs.com/en/business-wire.com/0274e24adeeb390ecd36e5a03bc1f293","width":480,"height":325}},"lazy":false},{"type":"image","alt":"","displaySize":"","headline":null,"caption":"","credit":null,"className":"","disableSlideshowImg":false,"size":{"original":{"width":2562,"height":408,"url":"https://media.zenfs.com/en/business-wire.com/4a05fe7e83db8c5cbe189b5b71e9ed28"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/5VW6WY8P.37g0lQoXTkAwA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTk2MDtoPTE1Mw--/https://media.zenfs.com/en/business-wire.com/4a05fe7e83db8c5cbe189b5b71e9ed28","width":960,"height":153},"lightbox":{"url":"https://s.yimg.com/ny/api/res/1.2/LEncwDRf8hw4..lxWBOrDA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTI0MDA7aD0zODI-/https://media.zenfs.com/en/business-wire.com/4a05fe7e83db8c5cbe189b5b71e9ed28","width":1200,"height":191}}},{"type":"text","content":"Starting today, eligible customers can access a broad assortment of treatment options, including the only FDA-approved GLP-1 weight loss pill","length":141,"tagName":"p","attribs":{}},{"type":"text","content":"SAN FRANCISCO, March 26, 2026--(BUSINESS WIRE)--Hims & Hers Health, Inc. (NYSE: HIMS) today announced that a broad assortment of Novo Nordisk’s FDA-approved GLP-1 medications are available to eligible customers, including the Wegovy® pill, which is the only FDA-approved GLP-1 weight loss pill.1 As a part of a collaboration with Novo Nordisk, Hims & Hers is making it simpler for customers to access FDA-approved GLP-1 medications which are now available at more affordable prices, with more doses and delivery methods. This expansion makes Hims & Hers the largest global consumer health platform for affordable access to approved medications.","length":...